H1B Salary Data

Home › Employers › Graviton Bioscience Corporation

Graviton Bioscience Corporation: H-1B salaries and sponsorship

Graviton Bioscience Corporation filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $213,271.

Applications (LCAs)3
Certified3
Employer addressNew York, NY
H-1B dependent employerNo
Median offered salary$213,271
Middle half of salaries$191,156–$235,386
10th–90th percentile$177,888–$248,654

Does Graviton Bioscience Corporation sponsor H-1B visas?

Graviton Bioscience Corporation filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 6, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Vice President AI & Operations2$257,500
Vice President of CMC Supply Chain1$169,042

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20241$169,042
FY20252$257,500

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Vice President AI & Operations$157,040
part-time · Level II
New York, NYJun 6, 2025Oct 1, 2025Certified
Vice President AI & Operations$257,500
Level II
New York, NYJun 5, 2025Oct 1, 2025Certified
Vice President of CMC Supply Chain$169,042–$185,000
Level IV
New York, NYMay 1, 2024May 6, 2024Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).